Psychiatric Comorbidity Among Adults with Schizophrenia: a Latent Class Analysis

Overview

Journal Psychiatry Res

Specialty Psychiatry

Date 2013 Jun 4

PMID 23726869

Citations 32

Authors

Jack Tsai

Robert A Rosenheck

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is a severe mental illness that often co-occurs with and can be exacerbated by other psychiatric conditions. There have not been adequate efforts to examine schizophrenia and psychiatric comorbidity beyond pairwise examination using clusters of diagnoses. This study used latent class analysis to characterize patterns of 5-year psychiatric comorbidity among a national sample of adults with schizophrenia. Baseline data from 1446 adults with schizophrenia across 57 sites in the United States were analyzed. Three latent classes were identified labeled Solely Schizophrenia, Comorbid Anxiety and Depressive Disorders with Schizophrenia, and Comorbid Addiction and Schizophrenia. Adults in the Solely Schizophrenia class had significantly better mental health than those in the two comorbid classes, but poorer illness and treatment insight than those with comorbid anxiety and depressive disorders. These results suggest that addiction and schizophrenia may represent a separate latent profile from depression, anxiety, and schizophrenia. More research is needed on how treatment can take advantage of the greater insight possessed by those with schizophrenia and comorbid anxiety and depression.

Citing Articles

Cardiovascular comorbidities in Chinese inpatients with schizophrenia spectrum disorders.

Dong Z, Wu G, Liu H, Chen S, Bi B, Zhang F Schizophrenia (Heidelb). 2025; 11(1):22.

PMID: 39971916 PMC: 11840127. DOI: 10.1038/s41537-025-00576-3.

Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV.

Miller E, McGinnis K, Edelman E, Feinberg T, Gordon K, Kerns R AIDS Behav. 2024; 28(12):3994-4004.

PMID: 39264485 PMC: 11586311. DOI: 10.1007/s10461-024-04494-w.

Predictors of Long-Acting Injectable Antipsychotic Medication Use in Patients with Schizophrenia Spectrum, Bipolar, and Other Psychotic Disorders in a US Community-based, Integrated Health System.

Alavi M, Ridout S, Lee C, Harris B, Ridout K Schizophr Bull Open. 2024; 5(1):sgae011.

PMID: 39144114 PMC: 11207847. DOI: 10.1093/schizbullopen/sgae011.

Substance Use Within Trials of Psychological Interventions for Psychosis: Sample Inclusion, Secondary Measures, and Intervention Effectiveness.

Halsall L, Ushakova A, Jones S, Chowdhury S, Goodwin L Schizophr Bull. 2024; 50(6):1489-1498.

PMID: 38777384 PMC: 11548936. DOI: 10.1093/schbul/sbae073.

Patterns of care and costs of switching oral antipsychotic medications in patients with schizophrenia initiating monotherapy treatment: A US claims analysis.

Fee R, Webb N, Dick L, White J, Essoi B, Walker V J Manag Care Spec Pharm. 2024; 30(6):560-571.

PMID: 38591754 PMC: 11145003. DOI: 10.18553/jmcp.2024.23274.

References

Emsley R, Oosthuizen P, Joubert A, Roberts M, Stein D . Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. J Clin Psychiatry. 1999; 60(11):747-51. DOI: 10.4088/jcp.v60n1105. View

Tibbo P, Swainson J, Chue P, LeMelledo J . Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia. Depress Anxiety. 2003; 17(2):65-72. DOI: 10.1002/da.10083. View

Drake R, Mueser K, Brunette M . Management of persons with co-occurring severe mental illness and substance use disorder: program implications. World Psychiatry. 2008; 6(3):131-6. PMC: 2174596. View

Garvey M, Noyes Jr R, Anderson D, Cook B . Examination of comorbid anxiety in psychiatric inpatients. Compr Psychiatry. 1991; 32(4):277-82. DOI: 10.1016/0010-440x(91)90075-n. View

Wolf E, Miller M, Reardon A, Ryabchenko K, Castillo D, Freund R . A latent class analysis of dissociation and posttraumatic stress disorder: evidence for a dissociative subtype. Arch Gen Psychiatry. 2012; 69(7):698-705. PMC: 3390764. DOI: 10.1001/archgenpsychiatry.2011.1574. View

Mueser K, Bellack A, Blanchard J . Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol. 1992; 60(6):845-56. DOI: 10.1037//0022-006x.60.6.845. View

Markou A, Kosten T, Koob G . Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 1998; 18(3):135-74. DOI: 10.1016/S0893-133X(97)00113-9. View

Stroup T, McEvoy J, Swartz M, Byerly M, Glick I, Canive J . The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull. 2003; 29(1):15-31. DOI: 10.1093/oxfordjournals.schbul.a006986. View

Regier D, Farmer M, Rae D, Locke B, Keith S, Judd L . Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990; 264(19):2511-8. View

10.

McEvoy J, Apperson L, Appelbaum P, Ortlip P, Brecosky J, Hammill K . Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis. 1989; 177(1):43-7. DOI: 10.1097/00005053-198901000-00007. View

11.

Lincoln T, Lullmann E, Rief W . Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr Bull. 2007; 33(6):1324-42. PMC: 2779879. DOI: 10.1093/schbul/sbm002. View

12.

Ginzburg K, Ein-Dor T, Solomon Z . Comorbidity of posttraumatic stress disorder, anxiety and depression: a 20-year longitudinal study of war veterans. J Affect Disord. 2009; 123(1-3):249-57. DOI: 10.1016/j.jad.2009.08.006. View

13.

Sim K, Mahendran R, Siris S, Heckers S, Chong S . Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res. 2004; 129(2):141-7. DOI: 10.1016/j.psychres.2004.07.007. View

14.

Achim A, Maziade M, Raymond E, Olivier D, Merette C, Roy M . How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2009; 37(4):811-21. PMC: 3122284. DOI: 10.1093/schbul/sbp148. View

15.

Bottas A, Cooke R, Richter M . Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia?. J Psychiatry Neurosci. 2005; 30(3):187-93. PMC: 1089779. View

16.

Pini S, Cassano G, DellOsso L, Amador X . Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am J Psychiatry. 2001; 158(1):122-5. DOI: 10.1176/appi.ajp.158.1.122. View

17.

Lieberman J, Stroup T, McEvoy J, Swartz M, Rosenheck R, Perkins D . Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353(12):1209-23. DOI: 10.1056/NEJMoa051688. View

18.

Poyurovsky M, Kriss V, Weisman G, Faragian S, Kurs R, Schneidman M . Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry. 2003; 64(11):1300-7. DOI: 10.4088/jcp.v64n1104. View

19.

Andreasen N, Flaum M, Swayze 2nd V, Tyrrell G, Arndt S . Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry. 1990; 47(7):615-21. DOI: 10.1001/archpsyc.1990.01810190015002. View

20.

Kessler R, Crum R, Warner L, Nelson C, Schulenberg J, Anthony J . Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997; 54(4):313-21. DOI: 10.1001/archpsyc.1997.01830160031005. View